Wild-Type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT02101944 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

NIH

Sponsor class

Conditions

Anemia
Recurrent Multiple Myeloma
Refractory Multiple Myeloma

Interventions

DRUG: Carfilzomib
DRUG: Dexamethasone
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Pelareorep

Sponsor

National Cancer Institute (NCI)